Patent · US Active

Engineered ligase variants

US12344872B2 · kind B2 · utility

0Cited by
132References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 7, 2018
Grant dateJul 1, 2025
Priority date
Expiry dateMay 7, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y605/01001
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides engineered ligase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered ligase polypeptides. The invention also provides methods for use of the compositions comprising the engineered ligase polypeptides for diagnostic and other purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.